| Risk score (High-risk/Low-risk) |
129/129 |
< 0.001 |
1.445 |
1.321 |
1.581 |
| Gender(male/female) |
118/140 |
0.439 |
1.172 |
0.784 |
1.751 |
| Age(< = 60/> 60) |
128/130 |
0.134 |
1.357 |
0.91 |
2.023 |
| Leiomyosarcoma histologic subtype(poorly differentiated or pleomorphic or epithelioid leiomyosarcoma/conventional leiomyosarcoma/well-differentiated leiomyosarcoma (resembling leiomyoma) |
34/64/4 |
0.025 |
0.592 |
0.303 |
0.924 |
| leiomyosarcoma major vessel involvement(yes/no) |
12/78 |
0.483 |
0.685 |
0.239 |
1.968 |
| New neoplasm event type(new primary tumor /distant metastasis/locoregional recurrence) |
5/41/29 |
0.668 |
0.885 |
0.506 |
1.548 |
| Local disease recurrence(yes/no) |
29/143 |
0.002 |
2.316 |
1.37 |
3.916 |
| Metastatic diagnosis(yes/no) |
56/119 |
< 0.001 |
3.009 |
1.831 |
4.946 |
| Tumor depth(deep/superficial) |
184/21 |
0.069 |
2.924 |
0.921 |
9.285 |
| Contiguous organ invaded(yes/no) |
14/43 |
0.012 |
2.809 |
1.261 |
6.261 |
| Margin status(positive/negative) |
73/136 |
0.013 |
1.84 |
1.138 |
2.974 |
| Person neoplasm cancer status(with tumor/tumor free) |
124/124 |
< 0.001 |
9.532 |
5.07 |
17.92 |
| Residual tumor(yes/no) |
154/78 |
< 0.001 |
2.553 |
1.668 |
3.909 |
| Tumor total necrosis percent(0/< 10%/> = 10%,< 50% |
12/61/38 |
0.121 |
1.207 |
0.952 |
1.532 |
| Radiation therapy(yes/no) |
73/179 |
0.508 |
0.882 |
0.566 |
1.376 |
| Treatment completion success outcome(SD/PD/CR/PR) |
124/3/8/64 |
< 0.001 |
2.386 |
1.795 |
3.171 |
